VAERS reports by lot

Moderna COVID-19 lot 017B22A: VAERS reports

217 VAERS reports list lot 017B22A as a Moderna COVID-19 vaccine, received between 2021-04-29 and 2024-10-22. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
217
Reports
18%
Marked serious
1
With a death outcome
18
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular16020%
General / Systemic (non-local)15719%
Neurological9812%
Gastrointestinal9011%
Respiratory8010%
Injection-site / Local reaction688%
Dermatological (non-injection-site)415%
Allergic / Anaphylactic344%
Musculoskeletal324%
Thrombotic / Hematological273%
Psychiatric / Neuropsychiatric111%
Autoimmune / Immune-mediated81%

Where reports came from

U.S. state of the reporter, where given (top 12).

Michigan30
New Jersey21
Georgia15
Texas12
Ohio12
California9
Washington8
Indiana8
New York8
Arizona6
Missouri5
Pennsylvania4

Reports by month received

2021-041
2022-064
2022-0786
2022-0835
2022-0911
2022-1018
2022-117
2022-1217
2023-018
2023-025
2023-034
2023-051
2023-0614
2023-071
2023-091
2023-102
2023-111
2024-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.